PAR
Click for more information
2.04% 25.0¢ paradigm biopharmaceuticals limited..

Hi Mozz, currently we have the SAS which gives access to...

  1. the buck
    63 Posts.
    lightbulb Created with Sketch. 29
    clock Created with Sketch.
    21/06/24
    11:16
    Post #: 74422510
    Hi Mozz, currently we have the SAS which gives access to pentosan currently via limited specialist request. Is it correct to assume TGA will mean any doctor can refer patients for pentosan treatment but treatment will not be covered by PBS…essentially just an easier process than the SAS….and still word of mouth only
    Last edited by the buck: Friday, 11:17
    PAR Price at posting: 23.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.0¢ 		Change
0.005(2.04%) 		Mkt cap ! $87.44M
Open High Low Value Volume
25.0¢ 25.5¢ 24.5¢ $96.12K 385.1K

Buyers (Bids)

No. Vol. Price($)
1 996 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 46407 3
View Market Depth
Last trade - 15.33pm 25/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.